Table 1 Characteristics of study subjects and lesions
Patient | Age(y) | Histologic type | Stage | Location | PTV(cm3) |
|---|---|---|---|---|---|
1 | 71 | NSCLC,NOS # | III | RUL | 62.1 cm3 |
2 | 64 | NSCLC, Squamous Cell Cancer | III | LUL | 119.5 cm3 |
3 | 49 | Thymoma # | III | 216.7 cm3 | |
4 | 62 | Small cell lung cancer | III | RUL | 253.5 cm3 |
5 | 54 | Thymoma # | III | 260.7 cm3 | |
6 | 52 | Esophagus, Squamous Cell Cancer # | III | 393.2 cm3 | |
7 | 41 | NSCLC, Squamous Cell Cancer | III | RLL | 639.8 cm3 |
8 | 56 | Esophagus, Squamous Cell Cancer | III | 660.6 cm3 | |
9 | 70 | NSCLC, Squamous Cell Cancer | III | Carina bronchial | 716.6 cm3 |
10 | 52 | NSCLC, Esophagus, Squamous Cell Cancer # | III | LLL | 732.8 cm3 |
11 | 72 | NSCLC, Squamous Cell Cancer | III | LLL | 804.9 cm3 |